论文信息 - Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway. - 字舞流文

Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway.

N. Yanaihara | A. Okamoto | N. Chiba | M. Saito | T. Kiyokawa | Y. Iida | Junya Tabata | Yuki Yoshino | M. Iwamoto | M. Takenaka | S. Yanagida | D. Noguchi